Compare MDGL & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDGL | ADT |
|---|---|---|
| Founded | 2011 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 6.6B |
| IPO Year | N/A | 2018 |
| Metric | MDGL | ADT |
|---|---|---|
| Price | $556.41 | $8.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $553.08 | $9.38 |
| AVG Volume (30 Days) | 317.0K | ★ 6.3M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | $740,640,000.00 | ★ $5,112,859,000.00 |
| Revenue This Year | $436.04 | $6.14 |
| Revenue Next Year | $53.17 | $3.69 |
| P/E Ratio | ★ N/A | $11.42 |
| Revenue Growth | ★ 864.21 | 6.29 |
| 52 Week Low | $265.00 | $6.71 |
| 52 Week High | $605.00 | $8.94 |
| Indicator | MDGL | ADT |
|---|---|---|
| Relative Strength Index (RSI) | 53.35 | 49.30 |
| Support Level | $546.20 | $7.97 |
| Resistance Level | $589.67 | $8.27 |
| Average True Range (ATR) | 19.77 | 0.13 |
| MACD | -6.95 | 0.03 |
| Stochastic Oscillator | 19.19 | 60.32 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).